Dr. Michael Busch Serving as International Society of Blood Transfusion President

8/25/2022

This summer, Vitalant Research Institute Director Emeritus and Vice President Michael Busch, M.D., Ph.D., became president of the International Society of Blood Transfusion.

Read more

Vitalant Research Institute: New Leader, Same Tradition of Research Excellence

7/19/2022

Vitalant Research Institute’s tradition of excellence in lifesaving research will continue under new leadership, as founder and Director Michael Busch, M.D., Ph.D., begins to wind down his storied career and transitions to a new role as director emeritus of Vitalant Research Institute while continuing as a vice president of research and scientific programs within Vitalant. After an extensive external and internal search, Brian Custer, Ph.D., M.P.H, was selected to lead the Research Institute as director and senior vice president of research and scientific programs with Vitalant.

Read more

Celebrating Women in Science

2/23/2022

The International Day of Women and Girls in Science, celebrated on Feb. 11, promotes full and equal access to and participation in science for women and girls, as well as honoring the achievements of women in the field.

According to the United Nations Educational, Scientific and Cultural Org (UNESCO0 Science Report, women account for only 33% of the world’s researchers¹. Here at Vitalant, women play vital roles across the organization, including at the Vitalant Research Institute.

Read more

Dr. Michael P. Busch, COVID Rescue Team honored with ABC awards

2/4/2022

Each year, America’s Blood Centers (ABC) recognizes individuals, civic groups, media and corporations for their commitment to community and national blood programs through their Awards of Excellence program.

Vitalant has been recognized with two awards this year: The illustrious Thomas F. Zuck Lifetime Achievement Award for Dr. Michael P. Busch and Outstanding Public Relations Campaign for the COVID Rescue Team.
Read More

Groundbreaking COVID-19 Blood Donor Seroprevalence Study Illustrates Increase in Population with Antibodies Because of Vaccination

9/2/2021

The largest nationwide SARS-CoV-2 seroprevalence survey, funded by the CDC and supported by 17 blood collection organizations representing blood donations from across all 50 states, Washington D.C., and Puerto Rico, published its latest findings in the Journal of the American Medical Association (JAMA). More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
Read More

The Vitalant Innovation Center begins transforming research into impact

8/10/2021

Vitalant is launching the Vitalant Innovation Center in Denver, Colorado, a key part of the Vitalant Research Institute. Vitalant is investing in the Innovation Center as part of its commitment to advancing the science of transfusion medicine. The center will provide scientific research and translational development expertise to design innovative processes for Vitalant and bring new products to the patients it serves.
Read More